Form 4: Nuvalent's Chief Development Officer Executes Stock Options and Sells Shares

Darlene Noci, Chief Development Officer of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock on March 22, 2024, according to a Form 4 filing with the SEC.

Summary

• On March 22, 2024, Darlene Noci, the Chief Development Officer of Nuvalent, Inc., engaged in transactions involving the company's Class A Common Stock.
• Noci exercised stock options to acquire 10,000 shares at $1.08 and another 10,000 shares at $14.40.
• Concurrently, Noci sold 13,100 shares at an average price of $77.25, 6,300 shares at an average price of $77.94, and 600 shares at an average price of $78.72.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 21, 2023.
• Following these transactions, Noci directly owns 33,300 shares of Class A Common Stock and holds options to purchase 70,362 additional shares.

Sentiment

Score: 5

Explanation: Neutral. This is a routine disclosure of stock transactions by a company executive. The transactions appear to be part of a pre-planned trading strategy.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.

Stakeholder Impact

• Shareholders can monitor insider transactions to gain insights into management's perspective on the company's stock value.
• The transactions themselves may have a minor impact on the stock's trading volume.

Key Dates